Review
A thorough and accessible reference guide to the MBA application process. A wonderful resource for anyone researching top business schools. --
Sharon J. Hoffman, Associate Dean and Director of the MBA Program, Stanford University Graduate School of BusinessA thorough and accessible reference guide to the MBA application process. A wonderful resource for anyone researching top business schools. --Sharon J. Hoffman, Associate Dean and Director of the MBA Program, Stanford University Graduate School of Business
An outstanding, well-organized and informative guide to access pertinent information about the top b-schools. --
Linda B. Meehan, Assistant Dean of Admissions, ColumbiaAn outstanding, well-organized and informative guide to access pertinent information about the top b-schools. --Linda B. Meehan, Asst Dean of Admissions, Columbia Business School
Essential reading for candidates - a realistic view of the different programs, helping candidates to ask themselves the right questions. --
Eric Chambers, Senior Associate Director of Admissions, WhartonEssential reading for candidates - a realistic view of the different programs, helping candidates to ask themselves the right questions. --Eric Chambers, Senior Associate Director of Admissions, Wharton
Product Description
The international edition of this bestselling book helps MBA candidates tailor their application to the schools of the choice. It provides in-depth analysis of the top b-schools: HBS, Stanford, Wharton, Chicago, INSEAD, Columbia, NYU, Kellogg, MIT, Berkeley and LBS. Recommendations on selecting schools, GMAT tips, and detailed, school-specific advice on putting together your application have made this the #1 bestseller for international student. "A wonderful resource" - Sharon Hoffman, Associate Dean, Stanford University "Accepted to Wharton thanks to your book" - Teddy Ngu This is the only book on MBAs that has been officially supported and sponsored by McKinsey & Company, BCG, Goldman Sachs, Bain & Company, Booz-Allen & Hamilton, AT Kearney, Novartis, Bertlesmann, Vivendi-Universal, Cap Gemini and Roland Berger & Partners.